在·维勒布兰德病的进展
Riitta Lassila1, Ferdows Atiq2,3, Caterina Casari4
1Research Program Unit in Systems Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Haemophilia : the official journal of the World Federation of Hemophilia
|December 17, 2025
概括
·威尔布兰德病 (VWD) 护理的进步落后于血友病,但新的诊断方法和新疗法正在出现. 持续宣传对于改善全球获得VWD治疗和诊断的机会至关重要.
科学领域:
- 血液学 血液学 血液学
- 罕见的出血障碍 罕见的出血障碍
背景情况:
- 与血友病相比,对·维勒布兰德病 (VWD) 的治疗进展有限.
- 目前的VWD治疗方法在二十年内基本没有变化,在预防和输液负担方面存在挑战.
研究的目的:
- 反思VWD (PwVWD) 患者的知识和护理的历史演变.
- 审查VWD目前的诊断方法.
- 突出新兴的新型治疗方案的景观VWD.
主要方法:
- 文学评论和对VWD护理历史的反思.
- 对VWD目前的诊断策略的分析.
- 概述VWD近期和即将到来的治疗发展.
主要成果:
- 在VWD和血友病之间的治疗进展中存在显著的差异.
- 现有的VWD治疗方法面临广泛预防性使用的局限性.
- 多种新的VWD疗法正在进入临床开发.
结论:
- 迫切需要改善国际上对VWD诊断和治疗的准入.
- 新型治疗方法的发展为VWD护理的实质性改进提供了希望.
- 为了推进VWD管理,PwVWD和医疗保健提供者的持续倡导是必不可少的.
相关概念视频
Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Structure and Function of Platelets
2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K


